On the two-year anniversary of the reignited Cancer Moonshot, the American Cancer Society Cancer Action Network (ACS CAN) is calling on the White House and Congress to reinforce their commitment to end cancer as we know it by taking key steps to prioritize cancer prevention and research.
Our 25 organizations, representing patients with serious health conditions and providers who care for them, urge the Supreme Court to reverse the Fifth Circuit’s decision in Alliance for Hippocratic Medicine et al. v FDA et al. because it threatens patients’ and providers’ ability to rely on Food and Drug Administration (FDA) decisions about drug safety.
The American Cancer Society Cancer Action Network (ACS CAN) released a new report today, Cancer in Medicare: An American Cancer Society Cancer Action Network Chartbook, to illustrate how the Medicare program serves patients across the cancer continuum as well as specific public policy recommendations to improve and strengthen the program. Given an individual’s cancer risk increases with age, Medicare plays a key role in reducing suffering and death from cancer.
Yesterday, the U.S. Court of Appeals for the Second Circuit issued a decision in the case of Haller v. Health and Human Services (HHS) upholding the U.S. District Court’s ruling preserving the provisions of the No Surprises Act (NSA) that prohibit patients from receiving surprise bills for unexpected out-of-network costs. However, the case was remanded back to the lower court for reconsideration of the issue of payments between providers and insurers.
Today, the Supreme Court of the United States will hear oral arguments in the case of Loper Bright Enterprises v. Raimondo and its companion case, Relentless v. Dept. of Commerce. The cases put in question the “Chevron deference” that protects the legal stability of public health programs like Medicare and Medicaid that benefit nearly half of the U.S. population by ensuring that laws passed by Congress can continue to be interpreted and implemented by expert federal agencies such as the Centers for Medicare and Medicaid Services (CMS).
WASHINGTON, D.C. – January 8, 2024 — Public health groups are urging the U.S. Court of Appeals for the Fifth Circuit to preserve protections in the Affordable Care Act (ACA) for Lesbian, Gay, Bisexual, Transgender and Queer (LGBTQ+) patients receiving health care services when it hears oral arguments today in the case of Neese v. Becerra.
The American Cancer Society Cancer Action Network (ACS CAN) announces two new members –– alongside newly-elected leadership officers to the Board of Directors, with terms that began on January 1, 2024. The Board provides leadership and guidance for ACS CAN, the advocacy affiliate of the American Cancer Society, which supports evidence-based policy and legislative solutions designed to end cancer as we know it, for everyone.
Today, the U.S. Court of Appeals for the Second Circuit will hear oral arguments in the case of Haller v. Health and Human Services (HHS) and decide whether or not to uphold the U.S. District Court’s ruling preserving the No Surprises Act (NSA), legislation that prohibits patients from receiving surprise bills for unexpected out-of-network costs.
Today, the American Cancer Society Cancer Action Network joined 21 groups representing millions of cancer patients, survivors and caregivers, to send a letter to the White House supporting the U.S. Food and Drug Administration proposed rules to eliminate the sale of menthol in cigarettes and all flavors in cigars.
The National Institutes of Standards and Technology proposed new guidance late last week that seeks to expand conditions under which federal government agencies can apply march-in rights, a provision of the 1980 Bayh-Doyle Act, to include consideration for pricing of pharmaceutical drugs.